About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Hrastm1Jaf
targeted mutation 1, James A Fagin
MGI:3845022
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Hrastm1Jaf/Hrastm1Jaf
Nf2tm2Gth/Nf2tm2Gth
Tg(TPO-cre)1Shk/0
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr MGI:5784770
cn2
Hrastm1Jaf/Hrastm1Jaf
Trp53tm1Brn/Trp53tm1Brn
Tg(TPO-cre)1Shk/0
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr MGI:5784771
cn3
Hrastm1Jaf/Hrastm1Jaf
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
involves: 129S1/Sv * 129S6/SvEvTac * FVB/NCr MGI:5784778
cn4
Hrastm1Jaf/Hras+
Tg(CAG-cre)13Miya/0
involves: 129S6/SvEvTac * Black Swiss * C57BL/6 MGI:3845065
cn5
Hrastm1Jaf/Hrastm1Jaf
Tg(TPO-cre)1Shk/0
involves: 129S6/SvEvTac * FVB/NCr MGI:5784765
cn6
Hrastm1Jaf/?
Tg(TPO-cre)1Shk/0
involves: 129S6/SvEvTac * FVB/NCr MGI:5779651


Genotype
MGI:5784770
cn1
Allelic
Composition
Hrastm1Jaf/Hrastm1Jaf
Nf2tm2Gth/Nf2tm2Gth
Tg(TPO-cre)1Shk/0
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Nf2tm2Gth mutation (3 available); any Nf2 mutation (65 available)
Tg(TPO-cre)1Shk mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mice develop large thyroid cancers with high penetrance, with most being poorly differentiated thyroid cancer
• treatment with AZD6244 results in a reduction of tumor size

neoplasm
• mice develop large thyroid cancers with high penetrance, with most being poorly differentiated thyroid cancer
• treatment with AZD6244 results in a reduction of tumor size

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
thyroid cancer DOID:1781 J:231492




Genotype
MGI:5784771
cn2
Allelic
Composition
Hrastm1Jaf/Hrastm1Jaf
Trp53tm1Brn/Trp53tm1Brn
Tg(TPO-cre)1Shk/0
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Tg(TPO-cre)1Shk mutation (1 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mice develop poorly differentiated thyroid cancer

neoplasm
• mice develop poorly differentiated thyroid cancer

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
thyroid cancer DOID:1781 J:231492




Genotype
MGI:5784778
cn3
Allelic
Composition
Hrastm1Jaf/Hrastm1Jaf
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * FVB/NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Ptentm2.1Ppp mutation (0 available); any Pten mutation (81 available)
Tg(TPO-cre)1Shk mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mice develop poorly differentiated thyroid cancer

neoplasm
• mice develop poorly differentiated thyroid cancer

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
thyroid cancer DOID:1781 J:231492




Genotype
MGI:3845065
cn4
Allelic
Composition
Hrastm1Jaf/Hras+
Tg(CAG-cre)13Miya/0
Genetic
Background
involves: 129S6/SvEvTac * Black Swiss * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Tg(CAG-cre)13Miya mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice that survive until weaning continue to have a high mortality rate
• greater than 80% of pups die in the first two weeks of life

craniofacial
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• increase in proliferation of progenitor cells in the cervical loop and transit-amplifying region of the tooth and the length of the transit-amplifying region is shorter
• increase in proliferation of progenitor cells in the cervical loop
• the stellate reticulum is disorganized
• ameloblasts and the underlying stratum intermedium are disorganized and the well-defined border between ameloblasts and stratum intermedium is lost
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• growth of ameloblasts is disorganized with detachment of the ameloblasts from the adjacent dentin, loss of polarity, and stratification occurring (J:148393)
• ameloblasts are disorganized, crowded and there is an increase in the number of ameloblasts at both the secretory and maturation stages (J:204891)
• ameloblasts have abnormal cell polarity at the secretory and maturation stages, with misorientation of nuclei and Golgi (J:204891)
• teeth show an increase in the distance between the cervical loop region and the appearance of the enamel protein amelogenin compared with controls, suggesting that ameloblasts show a delay in differentiation
• mice have irregular deposition of enamel (J:148393)
• incisor enamel is less densely mineralized at all stages examined and total volume of enamel is decreased, with enamel covering a decreased percent of the surface area of the tooth (J:204891)
• the interdigitated and highly organized pattern is lost in the enamel of incisors and the enamel rods intersect at irregular angles and do not completely span the dentin-enamel junction to the enamel surface
• molars show little to no enamel
• treatment of mice with a MEK inhibitor for 28 days rescues the enamel defect
• malocclusion occurs in these mice
• large cysts in the bone in the region of the third molar at P21
• cysts are lined by epithelium infiltrated by ghost cells, or aneucleic cells with basophilic granules
• cysts are near, but not associated with, the third molar, suggesting calcifying odontogenic cysts
• cysts are not observed at P70, indicating they resolve in adulthood
• the ratio of the cephalo-caudal to ventro-dorsal cranial axes is significantly smaller than controls
• nasal septal deviation is prominent in these mice

growth/size/body
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• increase in proliferation of progenitor cells in the cervical loop and transit-amplifying region of the tooth and the length of the transit-amplifying region is shorter
• increase in proliferation of progenitor cells in the cervical loop
• the stellate reticulum is disorganized
• ameloblasts and the underlying stratum intermedium are disorganized and the well-defined border between ameloblasts and stratum intermedium is lost
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• growth of ameloblasts is disorganized with detachment of the ameloblasts from the adjacent dentin, loss of polarity, and stratification occurring (J:148393)
• ameloblasts are disorganized, crowded and there is an increase in the number of ameloblasts at both the secretory and maturation stages (J:204891)
• ameloblasts have abnormal cell polarity at the secretory and maturation stages, with misorientation of nuclei and Golgi (J:204891)
• teeth show an increase in the distance between the cervical loop region and the appearance of the enamel protein amelogenin compared with controls, suggesting that ameloblasts show a delay in differentiation
• mice have irregular deposition of enamel (J:148393)
• incisor enamel is less densely mineralized at all stages examined and total volume of enamel is decreased, with enamel covering a decreased percent of the surface area of the tooth (J:204891)
• the interdigitated and highly organized pattern is lost in the enamel of incisors and the enamel rods intersect at irregular angles and do not completely span the dentin-enamel junction to the enamel surface
• molars show little to no enamel
• treatment of mice with a MEK inhibitor for 28 days rescues the enamel defect
• malocclusion occurs in these mice
• large cysts in the bone in the region of the third molar at P21
• cysts are lined by epithelium infiltrated by ghost cells, or aneucleic cells with basophilic granules
• cysts are near, but not associated with, the third molar, suggesting calcifying odontogenic cysts
• cysts are not observed at P70, indicating they resolve in adulthood
• nasal septal deviation is prominent in these mice
• mice that survive until weaning are runted but catch up in weight to controls by 20 weeks of age

behavior/neurological
• the high mortality rate of neonates and the abnormal cranial/facial structures suggests pups have trouble suckling

neoplasm
• almost all mice develop papillomas in the forestomach by 13 months of age
• angiosarcomas develop in about 40% of older mice
• papillomas are occasionally found in the anal epithelium
• 88% of mice develop skin papillomas by 58 weeks of age
• they are frequently found in the skull, face, and external auditory canal

cardiovascular system
• older mice (40-58 weeks) develop myocardial fibrosis

respiratory system
• nasal septal deviation is prominent in these mice

skeleton
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• increase in proliferation of progenitor cells in the cervical loop and transit-amplifying region of the tooth and the length of the transit-amplifying region is shorter
• increase in proliferation of progenitor cells in the cervical loop
• the stellate reticulum is disorganized
• ameloblasts and the underlying stratum intermedium are disorganized and the well-defined border between ameloblasts and stratum intermedium is lost
• mice show residual enamel matrix, indicating that ameloblasts do not completely remove the enamel matrix to form properly mineralized enamel
• growth of ameloblasts is disorganized with detachment of the ameloblasts from the adjacent dentin, loss of polarity, and stratification occurring (J:148393)
• ameloblasts are disorganized, crowded and there is an increase in the number of ameloblasts at both the secretory and maturation stages (J:204891)
• ameloblasts have abnormal cell polarity at the secretory and maturation stages, with misorientation of nuclei and Golgi (J:204891)
• teeth show an increase in the distance between the cervical loop region and the appearance of the enamel protein amelogenin compared with controls, suggesting that ameloblasts show a delay in differentiation
• mice have irregular deposition of enamel (J:148393)
• incisor enamel is less densely mineralized at all stages examined and total volume of enamel is decreased, with enamel covering a decreased percent of the surface area of the tooth (J:204891)
• the interdigitated and highly organized pattern is lost in the enamel of incisors and the enamel rods intersect at irregular angles and do not completely span the dentin-enamel junction to the enamel surface
• molars show little to no enamel
• treatment of mice with a MEK inhibitor for 28 days rescues the enamel defect
• malocclusion occurs in these mice
• large cysts in the bone in the region of the third molar at P21
• cysts are lined by epithelium infiltrated by ghost cells, or aneucleic cells with basophilic granules
• cysts are near, but not associated with, the third molar, suggesting calcifying odontogenic cysts
• cysts are not observed at P70, indicating they resolve in adulthood
• the ratio of the cephalo-caudal to ventro-dorsal cranial axes is significantly smaller than controls

integument
• 88% of mice develop skin papillomas by 58 weeks of age
• they are frequently found in the skull, face, and external auditory canal

digestive/alimentary system
• almost all mice develop papillomas in the forestomach by 13 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Costello syndrome DOID:0050469 OMIM:218040
J:204891




Genotype
MGI:5784765
cn5
Allelic
Composition
Hrastm1Jaf/Hrastm1Jaf
Tg(TPO-cre)1Shk/0
Genetic
Background
involves: 129S6/SvEvTac * FVB/NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Tg(TPO-cre)1Shk mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• mice do not develop thyroid cancer




Genotype
MGI:5779651
cn6
Allelic
Composition
Hrastm1Jaf/?
Tg(TPO-cre)1Shk/0
Genetic
Background
involves: 129S6/SvEvTac * FVB/NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Jaf mutation (0 available); any Hras mutation (30 available)
Tg(TPO-cre)1Shk mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• mice exhibit normal serum thyroid-stimulating hormone (TSH) and thyroxine (T4) levels

neoplasm
N
• mice treated with the goitrogen 6-propyl-2-thiouracil (PTU) for up to 20 weeks of age develop benign goiters and increases in TSH but do not develop thyroid cancer





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory